108 related articles for article (PubMed ID: 28960827)
1. The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments.
van Stam MA; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Aaronson NK; Ruud Bosch JLH
BJU Int; 2018 Mar; 121(3):405-414. PubMed ID: 28960827
[TBL] [Abstract][Full Text] [Related]
2. [The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments].
van Stam MA; Aaronson NK; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Bosch JLHR
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040303
[TBL] [Abstract][Full Text] [Related]
3. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
[TBL] [Abstract][Full Text] [Related]
5. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
6. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
7. Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.
Lehto US; Tenhola H; Taari K; Aromaa A
Br J Cancer; 2017 Mar; 116(7):864-873. PubMed ID: 28222069
[TBL] [Abstract][Full Text] [Related]
8. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
9. Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population.
Becker A; Tennstedt P; Hansen J; Trinh QD; Kluth L; Atassi N; Schlomm T; Salomon G; Haese A; Budaeus L; Michl U; Heinzer H; Huland H; Graefen M; Steuber T
BJU Int; 2014 Jul; 114(1):38-45. PubMed ID: 24053677
[TBL] [Abstract][Full Text] [Related]
10. Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy.
Kendel F; Helbig L; Neumann K; Herden J; Stephan C; Schrader M; Gaissmaier W
Int J Cancer; 2016 Aug; 139(4):749-53. PubMed ID: 27038059
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
Madalinska JB; Essink-Bot ML; de Koning HJ; Kirkels WJ; van der Maas PJ; Schröder FH
J Clin Oncol; 2001 Mar; 19(6):1619-28. PubMed ID: 11250990
[TBL] [Abstract][Full Text] [Related]
12. Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
Sun M; Abdollah F; Hansen J; Trinh QD; Bianchi M; Tian Z; Briganti A; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
J Sex Med; 2012 Nov; 9(11):2961-9. PubMed ID: 22672479
[TBL] [Abstract][Full Text] [Related]
13. Complications from treatment for prostate carcinoma among men in the Detroit area.
Schwartz K; Bunner S; Bearer R; Severson RK
Cancer; 2002 Jul; 95(1):82-9. PubMed ID: 12115320
[TBL] [Abstract][Full Text] [Related]
14. Time course and predictors of symptoms after primary prostate cancer therapy.
Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.
van Stam MA; Aaronson NK; Pos FJ; Bosch JL; Kieffer JM; Tillier CN; van der Poel HG
Eur Urol; 2016 Nov; 70(5):751-757. PubMed ID: 27016464
[TBL] [Abstract][Full Text] [Related]
16. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck.
Geiger-Gritsch S; Oberaigner W; Mühlberger N; Siebert U; Ladurner M; Klocker H; Horninger W
Urol Int; 2015; 94(4):419-27. PubMed ID: 25662301
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
[TBL] [Abstract][Full Text] [Related]
19. Changes in continence and health-related quality of life after curative treatment and watchful waiting of prostate cancer.
Katz G; Rodriguez R
Urology; 2007 Jun; 69(6):1157-60. PubMed ID: 17572206
[TBL] [Abstract][Full Text] [Related]
20. Is radical prostatectomy the "gold standard" for localized prostate cancer?
Mendenhall WM; Nichols RC; Henderson R; Mendenhall NP
Am J Clin Oncol; 2010 Oct; 33(5):511-5. PubMed ID: 20010078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
